|6.24||-0.065 / -1.03%|
As of 3:59pm ET
|6.21||-0.03 / -0.48%|
The 3 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 7.00. The median estimate represents a +92.31% increase from the last price of 6.24.
The current consensus among 3 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.